| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.907 | 0.004 | 0.924 | Analgesic | 0.924 0.004 DB14682 0.903 0.004 DBMET00225 0.796 0.006 DBMET00595 0.857 0.005 DBMET01317 0.921 0.004 DBMET01318 0.785 0.007 DBMET01319 0.85 0.005 DBMET01320 | DB14682 | |
| 0.84 | 0.003 | 0.85 | 5 Hydroxytryptamine release stimulant | 0.85 0.003 DB14682 0.768 0.004 DBMET00225 0.788 0.004 DBMET00595 0.529 0.023 DBMET01317 0.783 0.004 DBMET01318 0.676 0.009 DBMET01319 0.312 0.066 DBMET01320 | DB14682 | |
| 0.759 | 0.002 | 0.761 | Sigma receptor agonist | 0.761 0.002 DB14682 0.705 0.003 DBMET00225 0.663 0.003 DBMET00595 0.707 0.003 DBMET01317 0.706 0.003 DBMET01318 0.586 0.005 DBMET01319 0.638 0.004 DBMET01320 | DB14682 | |
| 0.754 | 0.003 | 0.796 | Analgesic, opioid | 0.796 0.002 DB14682 0.677 0.003 DBMET00225 0.572 0.004 DBMET00595 0.71 0.003 DBMET01317 0.741 0.003 DBMET01318 0.477 0.004 DBMET01319 0.626 0.003 DBMET01320 | DB14682 | |
| 0.747 | 0.003 | 0.785 | Opioid antagonist | 0.785 0.002 DB14682 0.685 0.003 DBMET00225 0.581 0.004 DBMET00595 0.67 0.003 DBMET01317 0.745 0.003 DBMET01318 0.468 0.004 DBMET01319 0.578 0.004 DBMET01320 | DB14682 | |
| 0.737 | 0.002 | 0.771 | Opioid agonist | 0.771 0.002 DB14682 0.682 0.003 DBMET00225 0.546 0.004 DBMET00595 0.676 0.003 DBMET01317 0.733 0.002 DBMET01318 0.416 0.004 DBMET01319 0.607 0.003 DBMET01320 | DB14682 | |
| 0.704 | 0.003 | 0.752 | Opioid mu receptor antagonist | 0.752 0.002 DB14682 0.633 0.003 DBMET00225 0.544 0.004 DBMET00595 0.63 0.003 DBMET01317 0.701 0.003 DBMET01318 0.435 0.004 DBMET01319 0.549 0.004 DBMET01320 | DB14682 | |
| 0.677 | 0.002 | 0.717 | Opioid mu receptor agonist | 0.717 0.002 DB14682 0.627 0.003 DBMET00225 0.498 0.003 DBMET00595 0.622 0.003 DBMET01317 0.668 0.002 DBMET01318 0.356 0.004 DBMET01319 0.521 0.003 DBMET01320 | DB14682 | |
| 0.66 | 0.003 | 0.715 | Opioid delta receptor antagonist | 0.715 0.002 DB14682 0.581 0.003 DBMET00225 0.361 0.004 DBMET00595 0.48 0.004 DBMET01317 0.667 0.003 DBMET01318 0.269 0.005 DBMET01319 0.312 0.005 DBMET01320 | DB14682 | |
| 0.659 | 0.002 | 0.692 | Opioid kappa receptor antagonist | 0.692 0.002 DB14682 0.603 0.003 DBMET00225 0.493 0.003 DBMET00595 0.572 0.003 DBMET01317 0.641 0.002 DBMET01318 0.429 0.004 DBMET01319 0.482 0.003 DBMET01320 | DB14682 | |
| 0.66 | 0.008 | 0.796 | Spasmolytic | 0.699 0.006 DB14682 0.53 0.02 DBMET00225 0.796 0.004 DBMET00595 0.62 0.011 DBMET01317 0.58 0.015 DBMET01318 0.682 0.007 DBMET01319 0.482 0.026 DBMET01320 | DBMET00595 | |
| 0.631 | 0.003 | 0.631 | Acetylcholine nicotinic antagonist | 0.61 0.003 DB14682 0.583 0.004 DBMET00225 0.12 0.03 DBMET00595 0.224 0.011 DBMET01317 0.558 0.004 DBMET01318 0.101 0.038 DBMET01319 0.189 0.014 DBMET01320 | ||
| 0.571 | 0.005 | 0.571 | Alpha adrenoreceptor antagonist | 0.4 0.009 DB14682 0.494 0.006 DBMET00225 0.181 0.031 DBMET01317 0.332 0.013 DBMET01318 0.138 0.041 DBMET01320 | ||
| 0.569 | 0.007 | 0.598 | Psychostimulant | 0.587 0.006 DB14682 0.411 0.021 DBMET00225 0.598 0.006 DBMET00595 0.427 0.019 DBMET01318 0.436 0.017 DBMET01319 | DBMET00595 | |
| 0.56 | 0.003 | 0.56 | Neuronal nicotinic receptor antagonist | 0.529 0.003 DB14682 0.502 0.003 DBMET00225 0.073 0.043 DBMET00595 0.188 0.009 DBMET01317 0.47 0.004 DBMET01318 0.061 0.053 DBMET01319 0.165 0.011 DBMET01320 | ||
| 0.559 | 0.003 | 0.631 | Opioid delta receptor agonist | 0.631 0.002 DB14682 0.448 0.003 DBMET00225 0.249 0.004 DBMET00595 0.31 0.004 DBMET01317 0.568 0.003 DBMET01318 0.146 0.005 DBMET01319 0.166 0.004 DBMET01320 | DB14682 | |
| 0.56 | 0.004 | 0.58 | Sigma receptor antagonist | 0.58 0.004 DB14682 0.473 0.004 DBMET00225 0.077 0.021 DBMET00595 0.203 0.009 DBMET01317 0.493 0.004 DBMET01318 0.054 0.032 DBMET01319 0.12 0.014 DBMET01320 | DB14682 | |
| 0.536 | 0.005 | 0.536 | Dopamine antagonist | 0.463 0.006 DB14682 0.35 0.009 DBMET00225 0.073 0.051 DBMET01317 0.287 0.012 DBMET01318 | ||
| 0.531 | 0.001 | 0.769 | NMDA receptor phencyclidine site antagonist | 0.683 0.001 DB14682 0.664 0.001 DBMET00225 0.017 0.009 DBMET00595 0.056 0.003 DBMET01317 0.769 0.001 DBMET01318 0.02 0.007 DBMET01319 0.071 0.003 DBMET01320 | DBMET01318 | |
| 0.516 | 0.005 | 0.516 | Dopamine D2 antagonist | 0.435 0.006 DB14682 0.345 0.009 DBMET00225 0.063 0.048 DBMET01317 0.27 0.012 DBMET01318 | ||
| 0.514 | 0.005 | 0.582 | Cholinergic antagonist | 0.582 0.004 DB14682 0.423 0.007 DBMET00225 0.199 0.032 DBMET00595 0.285 0.016 DBMET01317 0.49 0.005 DBMET01318 0.153 0.051 DBMET01319 0.22 0.027 DBMET01320 | DB14682 | |
| 0.511 | 0.005 | 0.578 | Acetylcholine antagonist | 0.578 0.004 DB14682 0.425 0.006 DBMET00225 0.175 0.038 DBMET00595 0.283 0.015 DBMET01317 0.489 0.005 DBMET01318 0.136 0.058 DBMET01319 0.222 0.026 DBMET01320 | DB14682 | |
| 0.509 | 0.004 | 0.509 | Alpha 2a adrenoreceptor antagonist | 0.451 0.004 DB14682 0.501 0.004 DBMET00225 0.082 0.047 DBMET01317 0.442 0.004 DBMET01318 0.08 0.049 DBMET01320 | ||
| 0.504 | 0.002 | 0.543 | Opioid kappa receptor agonist | 0.543 0.002 DB14682 0.413 0.002 DBMET00225 0.328 0.003 DBMET00595 0.418 0.002 DBMET01317 0.458 0.002 DBMET01318 0.293 0.003 DBMET01319 0.337 0.003 DBMET01320 | DB14682 | |
| 0.489 | 0.004 | 0.489 | Alpha 2 adrenoreceptor antagonist | 0.391 0.005 DB14682 0.466 0.004 DBMET00225 0.367 0.005 DBMET01318 | ||
| 0.484 | 0.005 | 0.484 | 5 Hydroxytryptamine 2B antagonist | 0.345 0.012 DB14682 0.215 0.024 DBMET00225 0.137 0.047 DBMET01318 | ||
| 0.481 | 0.003 | 0.772 | NMDA 2C receptor antagonist | 0.772 0.002 DB14682 0.457 0.003 DBMET00225 0.068 0.035 DBMET00595 0.695 0.002 DBMET01317 0.76 0.002 DBMET01318 0.065 0.038 DBMET01319 0.68 0.002 DBMET01320 | DB14682 | |
| 0.486 | 0.009 | 0.534 | Anesthetic general | 0.534 0.006 DB14682 0.321 0.029 DBMET00225 0.515 0.007 DBMET00595 0.379 0.019 DBMET01318 0.359 0.022 DBMET01319 | DB14682 | |
| 0.493 | 0.016 | 0.493 | HERG channel blocker | 0.403 0.027 DB14682 0.445 0.021 DBMET00225 0.351 0.037 DBMET01318 | ||
| 0.472 | 0.005 | 0.472 | Alpha 1 adrenoreceptor antagonist | 0.293 0.011 DB14682 0.328 0.009 DBMET00225 0.191 0.022 DBMET01318 | ||
| 0.467 | 0.005 | 0.467 | Alpha 1a adrenoreceptor antagonist | 0.285 0.01 DB14682 0.328 0.008 DBMET00225 0.187 0.018 DBMET01318 | ||
| 0.471 | 0.017 | 0.471 | Potassium channel (Voltage-sensitive) blocker | 0.361 0.034 DB14682 0.453 0.019 DBMET00225 0.34 0.039 DBMET01318 | ||
| 0.446 | 0.004 | 0.446 | Toll-Like receptor antagonist | 0.432 0.004 DB14682 0.402 0.004 DBMET00225 0.216 0.025 DBMET00595 0.385 0.004 DBMET01318 0.175 0.041 DBMET01319 | ||
| 0.445 | 0.004 | 0.445 | Nav1.6 sodium channel blocker | 0.377 0.004 DB14682 0.319 0.005 DBMET00225 0.138 0.069 DBMET01317 0.258 0.009 DBMET01318 | ||
| 0.444 | 0.004 | 0.577 | Dopamine D1 antagonist | 0.577 0.003 DB14682 0.289 0.006 DBMET00225 0.115 0.021 DBMET01317 0.402 0.004 DBMET01318 0.065 0.045 DBMET01320 | DB14682 | |
| 0.43 | 0.008 | 0.445 | Cholinergic | 0.38 0.011 DB14682 0.445 0.008 DBMET00225 0.154 0.074 DBMET00595 0.191 0.051 DBMET01317 0.394 0.01 DBMET01318 0.157 0.071 DBMET01319 0.197 0.048 DBMET01320 | DBMET00225 | |
| 0.41 | 0.004 | 0.41 | Acetylcholine agonist | 0.342 0.005 DB14682 0.404 0.004 DBMET00225 0.086 0.059 DBMET01317 0.336 0.005 DBMET01318 0.084 0.061 DBMET01320 | ||
| 0.406 | 0.004 | 0.424 | Nav1.1 sodium channel blocker | 0.424 0.004 DB14682 0.327 0.007 DBMET00225 0.191 0.021 DBMET00595 0.265 0.011 DBMET01317 0.343 0.006 DBMET01318 0.116 0.051 DBMET01319 0.161 0.029 DBMET01320 | DB14682 | |
| 0.396 | 0.007 | 0.455 | Antipruritic | 0.455 0.005 DB14682 0.376 0.008 DBMET00225 0.32 0.011 DBMET00595 0.241 0.028 DBMET01317 0.429 0.005 DBMET01318 0.302 0.014 DBMET01319 0.226 0.034 DBMET01320 | DB14682 | |
| 0.465 | 0.075 | 0.465 | Caspase 9 stimulant | 0.435 0.091 DB14682 0.452 0.082 DBMET00225 0.412 0.104 DBMET00595 0.421 0.099 DBMET01318 0.397 0.113 DBMET01319 | ||
| 0.391 | 0.003 | 0.408 | Toll-Like receptor 4 antagonist | 0.408 0.003 DB14682 0.37 0.003 DBMET00225 0.341 0.003 DBMET00595 0.261 0.004 DBMET01317 0.392 0.003 DBMET01318 0.323 0.003 DBMET01319 0.248 0.004 DBMET01320 | DB14682 | |
| 0.391 | 0.004 | 0.391 | Dopamine uptake inhibitor | 0.361 0.004 DB14682 0.281 0.004 DBMET00225 0.052 0.046 DBMET00595 0.061 0.037 DBMET01317 0.259 0.005 DBMET01318 | ||
| 0.388 | 0.006 | 0.455 | Acetylcholine M1 receptor antagonist | 0.455 0.004 DB14682 0.287 0.017 DBMET00225 0.183 0.05 DBMET00595 0.258 0.023 DBMET01317 0.341 0.009 DBMET01318 0.118 0.111 DBMET01319 0.173 0.056 DBMET01320 | DB14682 | |
| 0.386 | 0.012 | 0.386 | 5 Hydroxytryptamine antagonist | 0.206 0.032 DB14682 0.204 0.033 DBMET00225 0.103 0.076 DBMET01318 | ||
| 0.379 | 0.005 | 0.379 | Alpha 2b adrenoreceptor antagonist | 0.295 0.009 DB14682 0.337 0.007 DBMET00225 0.261 0.013 DBMET01318 | ||
| 0.372 | 0.005 | 0.372 | Nav1.3 sodium channel blocker | 0.296 0.009 DB14682 0.208 0.022 DBMET00225 0.167 0.038 DBMET01318 | ||
| 0.413 | 0.051 | 0.413 | Vasodilator, peripheral | 0.402 0.055 DB14682 0.23 0.144 DBMET00225 0.378 0.063 DBMET00595 0.223 0.151 DBMET01318 0.207 0.168 DBMET01319 | ||
| 0.362 | 0.002 | 0.468 | Prolactin inhibitor | 0.468 0.001 DB14682 0.33 0.003 DBMET00225 0.114 0.043 DBMET00595 0.22 0.006 DBMET01317 0.433 0.002 DBMET01318 0.095 0.061 DBMET01319 0.195 0.009 DBMET01320 | DB14682 | |
| 0.366 | 0.009 | 0.366 | Nav1.2 sodium channel blocker | 0.326 0.012 DB14682 0.294 0.015 DBMET00225 0.341 0.011 DBMET01317 0.252 0.021 DBMET01318 0.268 0.019 DBMET01320 | ||
| 0.415 | 0.06 | 0.78 | Transcription factor NF kappa B inhibitor | 0.49 0.046 DB14682 0.378 0.069 DBMET00225 0.78 0.014 DBMET00595 0.271 0.113 DBMET01317 0.457 0.052 DBMET01318 0.752 0.016 DBMET01319 0.244 0.132 DBMET01320 | DBMET00595 | |
| 0.38 | 0.026 | 0.388 | Potassium channel blocker | 0.269 0.058 DB14682 0.388 0.025 DBMET00225 0.276 0.055 DBMET01318 | DBMET00225 | |
| 0.384 | 0.034 | 0.434 | Hypoxia-inducible factor 1 alpha inhibitor | 0.399 0.03 DB14682 0.307 0.062 DBMET00225 0.434 0.023 DBMET00595 0.324 0.055 DBMET01318 0.359 0.042 DBMET01319 | DBMET00595 | |
| 0.35 | 0.005 | 0.438 | Dopamine agonist | 0.438 0.005 DB14682 0.306 0.005 DBMET00225 0.14 0.016 DBMET00595 0.346 0.005 DBMET01317 0.398 0.005 DBMET01318 0.122 0.02 DBMET01319 0.307 0.005 DBMET01320 | DB14682 | |
| 0.345 | 0.013 | 0.345 | 5 Hydroxytryptamine 2 antagonist | 0.209 0.028 DB14682 0.203 0.03 DBMET00225 0.118 0.06 DBMET01318 | ||
| 0.333 | 0.004 | 0.333 | Acetylcholine muscarinic agonist | 0.251 0.005 DB14682 0.297 0.004 DBMET00225 0.208 0.005 DBMET01318 | ||
| 0.332 | 0.005 | 0.332 | Dopamine D3 antagonist | 0.257 0.007 DB14682 0.198 0.011 DBMET00225 0.064 0.041 DBMET01317 0.143 0.016 DBMET01318 | ||
| 0.33 | 0.006 | 0.33 | Alpha 1b adrenoreceptor antagonist | 0.222 0.013 DB14682 0.25 0.01 DBMET00225 0.164 0.019 DBMET01318 | ||
| 0.349 | 0.029 | 0.349 | Anticonvulsant | 0.343 0.03 DB14682 0.277 0.047 DBMET00225 0.318 0.036 DBMET01317 0.273 0.048 DBMET01318 0.252 0.056 DBMET01320 | ||
| 0.325 | 0.005 | 0.325 | Alpha 2c adrenoreceptor antagonist | 0.25 0.01 DB14682 0.255 0.009 DBMET00225 0.204 0.017 DBMET01318 | ||
| 0.318 | 0.005 | 0.318 | Alpha 1d adrenoreceptor antagonist | 0.191 0.01 DB14682 0.231 0.008 DBMET00225 0.135 0.017 DBMET01318 | ||
| 0.38 | 0.073 | 0.61 | Antiobesity | 0.412 0.061 DB14682 0.432 0.054 DBMET00225 0.444 0.051 DBMET00595 0.567 0.025 DBMET01317 0.467 0.045 DBMET01318 0.482 0.041 DBMET01319 0.61 0.019 DBMET01320 | DBMET01320 | |
| 0.317 | 0.013 | 0.362 | Interleukin 6 antagonist | 0.347 0.01 DB14682 0.241 0.025 DBMET00225 0.362 0.009 DBMET00595 0.15 0.089 DBMET01317 0.274 0.019 DBMET01318 0.312 0.013 DBMET01319 | DBMET00595 | |
| 0.306 | 0.004 | 0.481 | Dopamine D2 agonist | 0.421 0.004 DB14682 0.104 0.01 DBMET00225 0.173 0.005 DBMET00595 0.481 0.004 DBMET01317 0.16 0.006 DBMET01318 0.074 0.016 DBMET01319 0.238 0.005 DBMET01320 | DBMET01317 | |
| 0.298 | 0.004 | 0.298 | Acetylcholine M1 receptor agonist | 0.225 0.004 DB14682 0.247 0.004 DBMET00225 0.176 0.005 DBMET01318 | ||
| 0.312 | 0.023 | 0.312 | 5 Hydroxytryptamine 1E antagonist | 0.299 0.03 DB14682 0.233 0.094 DBMET00225 0.213 0.116 DBMET01318 | ||
| 0.29 | 0.01 | 0.361 | Acetylcholine muscarinic antagonist | 0.361 0.005 DB14682 0.191 0.027 DBMET00225 0.127 0.06 DBMET00595 0.176 0.032 DBMET01317 0.242 0.016 DBMET01318 0.116 0.072 DBMET01320 | DB14682 | |
| 0.335 | 0.06 | 0.356 | Calcium channel activator | 0.282 0.11 DB14682 0.356 0.046 DBMET00225 0.304 0.088 DBMET01318 | DBMET00225 | |
| 0.275 | 0.008 | 0.81 | NMDA receptor antagonist | 0.632 0.004 DB14682 0.468 0.004 DBMET00225 0.565 0.004 DBMET01317 0.81 0.003 DBMET01318 0.106 0.044 DBMET01319 0.76 0.003 DBMET01320 | DBMET01318 | |
| 0.308 | 0.041 | 0.365 | 5 Hydroxytryptamine uptake stimulant | 0.336 0.03 DB14682 0.335 0.03 DBMET00225 0.365 0.022 DBMET01318 | DBMET01318 | |
| 0.276 | 0.01 | 0.276 | 5 Hydroxytryptamine 2C antagonist | 0.156 0.025 DB14682 0.151 0.026 DBMET00225 0.083 0.059 DBMET01318 | ||
| 0.275 | 0.016 | 0.275 | Acetylcholinesterase inhibitor | 0.238 0.023 DB14682 0.212 0.03 DBMET00225 0.108 0.092 DBMET01317 0.169 0.044 DBMET01318 | ||
| 0.265 | 0.014 | 0.265 | 5 Hydroxytryptamine 2A antagonist | 0.146 0.029 DB14682 0.14 0.031 DBMET00225 0.076 0.062 DBMET01318 | ||
| 0.252 | 0.004 | 0.562 | NMDA receptor subunit 3B antagonist | 0.562 0.002 DB14682 0.229 0.004 DBMET00225 0.044 0.03 DBMET00595 0.044 0.031 DBMET01317 0.528 0.002 DBMET01318 0.04 0.035 DBMET01319 0.039 0.036 DBMET01320 | DB14682 | |
| 0.308 | 0.064 | 0.526 | Aldehyde oxidase inhibitor | 0.526 0.029 DB14682 0.171 0.122 DBMET00225 0.314 0.063 DBMET01318 | DB14682 | |
| 0.247 | 0.004 | 0.289 | Dopamine D5 antagonist | 0.289 0.004 DB14682 0.191 0.005 DBMET00225 0.039 0.033 DBMET00595 0.082 0.012 DBMET01317 0.227 0.005 DBMET01318 0.058 0.02 DBMET01320 | DB14682 | |
| 0.245 | 0.003 | 0.245 | Sigma 2 receptor antagonist | 0.22 0.003 DB14682 0.088 0.005 DBMET00225 0.078 0.005 DBMET01318 | ||
| 0.336 | 0.094 | 0.539 | Immunosuppressant | 0.374 0.075 DB14682 0.394 0.066 DBMET00225 0.517 0.029 DBMET00595 0.307 0.11 DBMET01317 0.432 0.052 DBMET01318 0.539 0.023 DBMET01319 0.364 0.079 DBMET01320 | DBMET01319 | |
| 0.293 | 0.056 | 0.424 | Tumour necrosis factor alpha release inhibitor | 0.233 0.083 DB14682 0.224 0.09 DBMET00225 0.424 0.023 DBMET00595 0.19 0.118 DBMET01317 0.162 0.143 DBMET01318 0.385 0.029 DBMET01319 | DBMET00595 | |
| 0.239 | 0.007 | 0.737 | NMDA 2 receptor antagonist | 0.563 0.003 DB14682 0.318 0.005 DBMET00225 0.642 0.003 DBMET01317 0.668 0.003 DBMET01318 0.737 0.003 DBMET01320 | DBMET01320 | |
| 0.25 | 0.02 | 0.25 | Anesthetic local | 0.234 0.023 DB14682 0.119 0.068 DBMET00225 0.107 0.077 DBMET01318 | ||
| 0.239 | 0.018 | 0.241 | Antiadrenergic | 0.216 0.021 DB14682 0.241 0.018 DBMET00225 0.094 0.06 DBMET01317 0.217 0.021 DBMET01318 0.092 0.061 DBMET01320 | DBMET00225 | |
| 0.232 | 0.019 | 0.236 | Adrenaline antagonist | 0.209 0.022 DB14682 0.236 0.018 DBMET00225 0.09 0.06 DBMET01317 0.212 0.021 DBMET01318 0.089 0.061 DBMET01320 | DBMET00225 | |
| 0.227 | 0.014 | 0.227 | 5 Hydroxytryptamine 1 antagonist | 0.104 0.036 DB14682 0.089 0.042 DBMET00225 | ||
| 0.214 | 0.004 | 0.215 | Acetylcholine M3 receptor agonist | 0.21 0.004 DB14682 0.215 0.004 DBMET00225 0.167 0.012 DBMET00595 0.186 0.006 DBMET01317 0.211 0.004 DBMET01318 0.167 0.012 DBMET01319 0.186 0.006 DBMET01320 | DBMET00225 | |
| 0.218 | 0.013 | 0.218 | 5 Hydroxytryptamine 1A antagonist | 0.102 0.031 DB14682 0.103 0.031 DBMET00225 | ||
| 0.21 | 0.01 | 0.21 | 5 Hydroxytryptamine uptake inhibitor | 0.17 0.014 DB14682 0.18 0.013 DBMET00225 0.143 0.017 DBMET01318 | ||
| 0.21 | 0.011 | 0.223 | Antineoplastic alkaloid | 0.223 0.008 DB14682 0.194 0.015 DBMET00225 0.13 0.034 DBMET00595 0.099 0.048 DBMET01317 0.212 0.01 DBMET01318 0.105 0.044 DBMET01319 0.076 0.07 DBMET01320 | DB14682 | |
| 0.241 | 0.044 | 0.241 | P-glycoprotein inhibitor | 0.205 0.06 DB14682 0.177 0.083 DBMET00225 0.202 0.062 DBMET00595 0.149 0.118 DBMET01318 0.164 0.097 DBMET01319 | ||
| 0.192 | 0.004 | 0.688 | NMDA receptor subunit 3A antagonist | 0.551 0.002 DB14682 0.3 0.003 DBMET00225 0.033 0.031 DBMET00595 0.048 0.02 DBMET01317 0.688 0.002 DBMET01318 0.061 0.016 DBMET01319 0.085 0.01 DBMET01320 | DBMET01318 | |
| 0.258 | 0.072 | 0.613 | Hypoglycemic | 0.298 0.053 DB14682 0.183 0.13 DBMET00225 0.613 0.007 DBMET00595 0.221 0.095 DBMET01318 0.588 0.009 DBMET01319 | DBMET00595 | |
| 0.243 | 0.075 | 0.368 | Tyrosine 3 hydroxylase inhibitor | 0.344 0.017 DB14682 0.26 0.059 DBMET00225 0.368 0.012 DBMET01318 | DBMET01318 | |
| 0.197 | 0.031 | 0.197 | Calcium channel blocker | 0.116 0.091 DB14682 0.162 0.049 DBMET00225 | ||
| 0.17 | 0.008 | 0.17 | Adrenaline uptake inhibitor | 0.168 0.008 DB14682 0.157 0.009 DBMET00225 0.063 0.041 DBMET00595 0.066 0.038 DBMET01317 0.154 0.009 DBMET01318 0.056 0.049 DBMET01319 0.057 0.048 DBMET01320 | ||
| 0.161 | 0.002 | 0.171 | Prolactin release inhibitor | 0.171 0.002 DB14682 0.124 0.003 DBMET00225 0.116 0.003 DBMET00595 0.137 0.003 DBMET01317 0.133 0.003 DBMET01318 0.092 0.005 DBMET01319 0.106 0.004 DBMET01320 | DB14682 | |
| 0.171 | 0.016 | 0.171 | 5 Hydroxytryptamine 7 antagonist | 0.103 0.025 DB14682 | ||
| 0.168 | 0.014 | 0.168 | 5 Hydroxytryptamine 1F antagonist | 0.149 0.017 DB14682 | ||
| 0.152 | 0.004 | 0.221 | Nicotinic receptor beta4 subunit antagonist | 0.164 0.004 DB14682 0.2 0.003 DBMET00225 0.071 0.009 DBMET00595 0.105 0.006 DBMET01317 0.221 0.003 DBMET01318 0.104 0.006 DBMET01319 0.149 0.004 DBMET01320 | DBMET01318 | |
| 0.21 | 0.064 | 0.415 | Nitric oxide antagonist | 0.247 0.052 DB14682 0.177 0.078 DBMET00225 0.415 0.024 DBMET00595 0.168 0.083 DBMET01317 0.213 0.063 DBMET01318 0.395 0.026 DBMET01319 0.143 0.102 DBMET01320 | DBMET00595 | |
| 0.222 | 0.079 | 0.371 | Cyclic AMP phosphodiesterase inhibitor | 0.222 0.079 DB14682 0.371 0.021 DBMET00595 0.201 0.092 DBMET01319 | DBMET00595 | |
| 0.146 | 0.005 | 0.146 | Sigma 1 receptor antagonist | 0.138 0.005 DB14682 0.035 0.015 DBMET00225 0.031 0.016 DBMET01318 | ||
| 0.154 | 0.014 | 0.164 | Acetylcholine release stimulant | 0.116 0.055 DB14682 0.107 0.072 DBMET00225 0.124 0.042 DBMET00595 0.164 0.01 DBMET01317 0.115 0.056 DBMET01320 | DBMET01317 | |
| 0.149 | 0.01 | 0.149 | Acetylcholine M4 receptor antagonist | 0.113 0.02 DB14682 0.107 0.023 DBMET00225 0.084 0.042 DBMET01318 | ||
| 0.141 | 0.005 | 0.171 | Nociceptin (N/OFQ) receptor antagonist | 0.171 0.004 DB14682 0.098 0.006 DBMET00225 0.053 0.013 DBMET01317 0.127 0.005 DBMET01318 0.038 0.022 DBMET01320 | DB14682 | |
| 0.142 | 0.007 | 0.143 | Oxytocin antagonist | 0.137 0.007 DB14682 0.143 0.007 DBMET00225 0.044 0.021 DBMET01317 0.138 0.007 DBMET01318 0.043 0.021 DBMET01320 | DBMET00225 | |
| 0.135 | 0.003 | 0.135 | Acetylcholine M4 receptor agonist | 0.105 0.004 DB14682 0.106 0.004 DBMET00225 0.075 0.006 DBMET01318 | ||
| 0.17 | 0.038 | 0.3 | Glutamate receptor antagonist | 0.235 0.018 DB14682 0.223 0.02 DBMET00225 0.182 0.032 DBMET01317 0.3 0.01 DBMET01318 0.234 0.018 DBMET01320 | DBMET01318 | |
| 0.192 | 0.061 | 0.214 | Lipocortins synthesis antagonist | 0.214 0.048 DB14682 0.179 0.072 DBMET00225 0.192 0.061 DBMET00595 0.2 0.056 DBMET01318 0.183 0.068 DBMET01319 | DB14682 | |
| 0.138 | 0.01 | 0.138 | Alpha 1 adrenoreceptor agonist | 0.105 0.015 DB14682 0.114 0.014 DBMET00225 0.089 0.02 DBMET01318 | ||
| 0.138 | 0.01 | 0.138 | Nicotinic alpha4beta2 receptor antagonist | 0.13 0.013 DB14682 0.138 0.011 DBMET00225 0.129 0.014 DBMET01318 | ||
| 0.122 | 0.005 | 0.122 | Acetylcholine M2 receptor agonist | 0.116 0.005 DB14682 0.11 0.005 DBMET00225 0.065 0.024 DBMET00595 0.082 0.012 DBMET01317 0.106 0.006 DBMET01318 0.058 0.031 DBMET01319 0.075 0.016 DBMET01320 | ||
| 0.122 | 0.009 | 0.122 | Nicotinic receptor alpha7 subunit antagonist | 0.106 0.011 DB14682 0.115 0.01 DBMET00225 0.099 0.012 DBMET01318 | ||
| 0.236 | 0.125 | 0.272 | Caspase 3 stimulant | 0.224 0.138 DB14682 0.272 0.095 DBMET00595 0.23 0.132 DBMET01319 | DBMET00595 | |
| 0.117 | 0.009 | 0.117 | Glycine transporter inhibitor | 0.083 0.016 DB14682 0.099 0.012 DBMET00225 0.069 0.021 DBMET01318 | ||
| 0.312 | 0.204 | 0.736 | Antiinflammatory | 0.418 0.128 DB14682 0.281 0.234 DBMET00225 0.736 0.025 DBMET00595 0.461 0.105 DBMET01317 0.389 0.146 DBMET01318 0.731 0.025 DBMET01319 0.438 0.116 DBMET01320 | DBMET00595 | |
| 0.115 | 0.009 | 0.14 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.14 0.006 DB14682 0.041 0.04 DBMET00595 0.049 0.031 DBMET01317 0.053 0.027 DBMET01318 | DB14682 | |
| 0.242 | 0.137 | 0.309 | Sodium/bile acid cotransporter inhibitor | 0.309 0.071 DB14682 0.237 0.143 DBMET00225 0.254 0.124 DBMET00595 0.25 0.128 DBMET01317 0.307 0.073 DBMET01318 0.251 0.127 DBMET01319 0.246 0.132 DBMET01320 | DB14682 | |
| 0.124 | 0.02 | 0.124 | Alpha 2d adrenoreceptor antagonist | 0.122 0.022 DB14682 0.122 0.022 DBMET00225 0.092 0.065 DBMET01317 0.119 0.024 DBMET01318 0.088 0.075 DBMET01320 | ||
| 0.138 | 0.036 | 0.138 | Antihistaminic | 0.096 0.058 DB14682 0.093 0.06 DBMET00225 | ||
| 0.131 | 0.029 | 0.131 | Calcium antagonist | 0.09 0.056 DBMET00225 | ||
| 0.122 | 0.021 | 0.172 | Alpha adrenoreceptor agonist | 0.132 0.019 DB14682 0.165 0.014 DBMET00225 0.172 0.012 DBMET01318 | DBMET01318 | |
| 0.108 | 0.011 | 0.108 | Antidiuretic hormone antagonist | 0.103 0.012 DB14682 0.094 0.014 DBMET00225 0.086 0.015 DBMET01318 | ||
| 0.101 | 0.004 | 0.101 | Vasopressin 1B antagonist | 0.099 0.004 DB14682 0.099 0.004 DBMET00225 0.036 0.012 DBMET01317 0.096 0.004 DBMET01318 0.034 0.014 DBMET01320 | ||
| 0.104 | 0.009 | 0.139 | 5 Hydroxytryptamine 2 agonist | 0.07 0.019 DB14682 0.139 0.005 DBMET00225 0.089 0.012 DBMET01318 | DBMET00225 | |
| 0.138 | 0.043 | 0.199 | Interleukin 8 antagonist | 0.199 0.013 DB14682 0.106 0.083 DBMET00225 0.159 0.029 DBMET01318 | DB14682 | |
| 0.106 | 0.014 | 0.106 | 5 Hydroxytryptamine 5A antagonist | 0.079 0.024 DB14682 | ||
| 0.126 | 0.036 | 0.126 | Histamine antagonist | 0.083 0.061 DB14682 0.084 0.059 DBMET00225 | ||
| 0.101 | 0.012 | 0.101 | Dopamine transporter inhibitor | 0.098 0.012 DB14682 0.063 0.023 DBMET00225 0.059 0.026 DBMET01318 | ||
| 0.098 | 0.009 | 0.101 | Vasopressin 1 antagonist | 0.101 0.009 DB14682 0.083 0.011 DBMET00225 0.086 0.01 DBMET01318 | DB14682 | |
| 0.104 | 0.017 | 0.115 | Acetylcholine M5 receptor antagonist | 0.115 0.014 DB14682 0.059 0.044 DBMET00225 0.063 0.037 DBMET01318 | DB14682 | |
| 0.101 | 0.014 | 0.101 | 5 Hydroxytryptamine 2A agonist | 0.085 0.023 DB14682 0.097 0.016 DBMET00225 0.082 0.026 DBMET01318 | ||
| 0.107 | 0.021 | 0.107 | Calcium channel L-type blocker | 0.064 0.061 DB14682 0.087 0.033 DBMET00225 | ||
| 0.099 | 0.015 | 0.099 | 5 Hydroxytryptamine 5 antagonist | 0.065 0.03 DB14682 | ||
| 0.093 | 0.018 | 0.093 | Orexin receptor 1 antagonist | 0.071 0.051 DBMET00225 | ||
| 0.081 | 0.008 | 0.091 | Vasopressin 2 antagonist | 0.091 0.007 DB14682 0.077 0.009 DBMET00225 0.044 0.016 DBMET01317 0.087 0.007 DBMET01318 0.04 0.018 DBMET01320 | DB14682 | |
| 0.106 | 0.033 | 0.125 | Acetylcholine nicotinic agonist | 0.102 0.036 DB14682 0.125 0.025 DBMET00225 0.118 0.027 DBMET01318 | DBMET00225 | |
| 0.141 | 0.069 | 0.182 | Toll-Like receptor 9 antagonist | 0.182 0.044 DBMET00225 0.119 0.087 DBMET01318 | DBMET00225 | |
| 0.095 | 0.023 | 0.095 | Acetylcholine M5 receptor agonist | |||
| 0.096 | 0.025 | 0.096 | 5 Hydroxytryptamine 1B antagonist | 0.06 0.051 DB14682 | ||
| 0.089 | 0.018 | 0.089 | Orexin receptor antagonist | |||
| 0.208 | 0.137 | 0.227 | Gastrin inhibitor | 0.21 0.133 DB14682 0.224 0.113 DBMET00225 0.227 0.109 DBMET01318 0.184 0.174 DBMET01319 | DBMET01318 | |
| 0.077 | 0.008 | 0.083 | Vasopressin 1A antagonist | 0.083 0.007 DB14682 0.071 0.009 DBMET00225 0.078 0.008 DBMET01318 | DB14682 | |
| 0.143 | 0.074 | 0.324 | Protein kinase stimulant | 0.174 0.053 DB14682 0.136 0.078 DBMET00225 0.324 0.014 DBMET00595 0.168 0.057 DBMET01318 0.313 0.015 DBMET01319 | DBMET00595 | |
| 0.07 | 0.005 | 0.086 | Alpha 1L adrenoreceptor agonist | 0.065 0.007 DB14682 0.086 0.004 DBMET00225 0.055 0.012 DBMET01317 0.08 0.004 DBMET01318 0.047 0.021 DBMET01319 0.067 0.006 DBMET01320 | DBMET00225 | |
| 0.089 | 0.025 | 0.103 | Acetylcholine M2 receptor antagonist | 0.103 0.02 DB14682 | DB14682 | |
| 0.075 | 0.015 | 0.148 | Nicotinic receptor alpha4 subunit antagonist | 0.075 0.015 DB14682 0.146 0.004 DBMET00225 0.148 0.004 DBMET01318 0.053 0.028 DBMET01319 0.092 0.01 DBMET01320 | DBMET01318 | |
| 0.073 | 0.016 | 0.096 | Nicotinic alpha3beta2 receptor antagonist | 0.071 0.017 DB14682 0.096 0.008 DBMET00225 0.094 0.009 DBMET01318 | DBMET00225 | |
| 0.084 | 0.029 | 0.084 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.072 | 0.018 | 0.072 | 5 Hydroxytryptamine 7 agonist | 0.055 0.041 DB14682 0.063 0.027 DBMET00225 | ||
| 0.075 | 0.022 | 0.369 | NMDA 2A receptor antagonist | 0.204 0.005 DB14682 0.133 0.008 DBMET00225 0.1 0.013 DBMET01317 0.369 0.003 DBMET01318 0.179 0.005 DBMET01320 | DBMET01318 | |
| 0.068 | 0.016 | 0.07 | Nicotinic receptor alpha3 subunit antagonist | 0.07 0.015 DB14682 0.058 0.02 DBMET00225 0.059 0.019 DBMET01318 | DB14682 | |
| 0.051 | 0.005 | 0.062 | Nicotinic alpha3beta4 receptor agonist | 0.052 0.005 DB14682 0.062 0.004 DBMET00225 0.062 0.004 DBMET01318 | DBMET01318 | |
| 0.254 | 0.21 | 0.502 | Apoptosis agonist | 0.278 0.189 DB14682 0.502 0.074 DBMET00595 0.475 0.082 DBMET01319 | DBMET00595 | |
| 0.091 | 0.048 | 0.091 | Histamine H1 receptor antagonist | 0.079 0.058 DB14682 | ||
| 0.064 | 0.022 | 0.064 | 5 Hydroxytryptamine 1B agonist | 0.062 0.025 DB14682 | ||
| 0.053 | 0.011 | 0.067 | 5 Hydroxytryptamine 2B agonist | 0.039 0.027 DB14682 0.067 0.006 DBMET00225 0.047 0.015 DBMET01318 | DBMET00225 | |
| 0.072 | 0.03 | 0.129 | Acetylcholine M3 receptor antagonist | 0.129 0.013 DB14682 0.079 0.026 DBMET01318 | DB14682 | |
| 0.045 | 0.005 | 0.114 | Dopamine D1 agonist | 0.063 0.004 DB14682 0.08 0.004 DBMET00225 0.056 0.004 DBMET00595 0.068 0.004 DBMET01317 0.114 0.003 DBMET01318 0.081 0.004 DBMET01319 0.112 0.003 DBMET01320 | DBMET01318 | |
| 0.065 | 0.026 | 0.065 | Melanin-concentrating hormone receptor 1 antagonist | 0.049 0.042 DBMET00225 | ||
| 0.072 | 0.036 | 0.072 | Dopamine D4 antagonist | |||
| 0.044 | 0.01 | 0.078 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.078 0.005 DB14682 0.067 0.006 DBMET00595 | DB14682 | |
| 0.049 | 0.015 | 0.049 | 5 Hydroxytryptamine 3B antagonist | 0.037 0.023 DB14682 | ||
| 0.057 | 0.023 | 0.114 | 5 Hydroxytryptamine 2C agonist | 0.048 0.029 DB14682 0.114 0.006 DBMET00225 0.105 0.007 DBMET01318 0.053 0.026 DBMET01320 | DBMET00225 | |
| 0.103 | 0.072 | 0.137 | 5 Hydroxytryptamine 3A agonist | 0.137 0.043 DB14682 0.103 0.072 DBMET01318 | DB14682 | |
| 0.071 | 0.04 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.117 | 0.087 | 0.127 | Sodium channel (voltage-gated) blocker | 0.127 0.076 DBMET00225 | DBMET00225 | |
| 0.038 | 0.009 | 0.044 | Nicotinic alpha4beta2 receptor agonist | 0.034 0.013 DB14682 0.044 0.006 DBMET00225 0.04 0.008 DBMET01318 | DBMET00225 | |
| 0.165 | 0.137 | 0.318 | Vasodilator | 0.182 0.12 DB14682 0.164 0.138 DBMET00225 0.316 0.043 DBMET00595 0.181 0.121 DBMET01318 0.318 0.042 DBMET01319 | DBMET01319 | |
| 0.062 | 0.034 | 0.075 | Nicotinic neuronal receptor agonist | 0.075 0.024 DBMET00225 0.054 0.041 DBMET01318 | DBMET00225 | |
| 0.056 | 0.029 | 0.056 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.055 | 0.03 | 0.057 | Alpha 1L adrenoreceptor antagonist | 0.057 0.027 DBMET00225 | DBMET00225 | |
| 0.123 | 0.101 | 0.578 | Diuretic | 0.18 0.053 DB14682 0.39 0.014 DBMET00595 0.578 0.005 DBMET01317 0.26 0.029 DBMET01319 0.461 0.009 DBMET01320 | DBMET01317 | |
| 0.059 | 0.036 | 0.059 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.128 | 0.106 | 0.139 | Pregnane X receptor agonist | 0.139 0.075 DB14682 | DB14682 | |
| 0.086 | 0.065 | 0.086 | Phosphodiesterase I inhibitor | |||
| 0.041 | 0.02 | 0.074 | Glycine transporter 1 inhibitor | 0.074 0.009 DBMET00225 0.058 0.013 DBMET01318 | DBMET00225 | |
| 0.203 | 0.185 | 0.203 | Ca(v)3.3 blocker | |||
| 0.078 | 0.063 | 0.078 | Phosphodiesterase XI inhibitor | |||
| 0.078 | 0.063 | 0.078 | Phosphodiesterase 11A inhibitor | |||
| 0.07 | 0.055 | 0.092 | Glycine receptor agonist | 0.083 0.035 DB14682 0.077 0.043 DBMET00225 0.074 0.047 DBMET00595 0.092 0.026 DBMET01318 0.081 0.037 DBMET01319 | DBMET01318 | |
| 0.087 | 0.073 | 0.087 | Butyrylcholinesterase inhibitor | |||
| 0.098 | 0.087 | 0.098 | Calcium channel (voltage-sensitive) blocker | |||
| 0.037 | 0.027 | 0.038 | Delayed rectifier potassium channel blocker | 0.038 0.025 DB14682 | DB14682 | |
| 0.052 | 0.041 | 0.099 | Lysine-specific demethylase 1A inhibitor | 0.062 0.026 DB14682 0.081 0.012 DBMET00225 0.099 0.007 DBMET01318 | DBMET01318 | |
| 0.121 | 0.112 | 0.315 | NOS3 expression enhancer | 0.199 0.041 DB14682 0.315 0.016 DBMET00595 0.163 0.061 DBMET01318 0.292 0.019 DBMET01319 | DBMET00595 | |
| 0.102 | 0.094 | 0.17 | Estrogen antagonist | 0.165 0.019 DB14682 0.103 0.091 DBMET00225 0.17 0.018 DBMET01318 | DBMET01318 | |
| 0.079 | 0.071 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.028 DB14682 0.09 0.041 DBMET01318 | DB14682 | |
| 0.095 | 0.089 | 0.196 | Adenylate cyclase inhibitor | 0.166 0.036 DB14682 0.123 0.065 DBMET00225 0.104 0.081 DBMET00595 0.196 0.026 DBMET01318 0.131 0.059 DBMET01319 | DBMET01318 | |
| 0.056 | 0.052 | 0.056 | Phosphodiesterase 1A inhibitor | |||
| 0.033 | 0.029 | 0.033 | Orexin receptor 2 antagonist | |||
| 0.058 | 0.057 | 0.074 | 5 Hydroxytryptamine agonist | 0.074 0.044 DBMET00225 | DBMET00225 | |
| 0.053 | 0.052 | 0.089 | Alpha 2 adrenoreceptor agonist | 0.067 0.035 DB14682 0.073 0.029 DBMET00225 0.089 0.019 DBMET01318 | DBMET01318 | |
| 0.014 | 0.015 | 0.03 | Nicotinic alpha4 receptor agonist | 0.03 0.004 DBMET00225 0.023 0.005 DBMET01318 | DBMET00225 | |
| 0.018 | 0.019 | 0.025 | Nociceptin (N/OFQ) receptor agonist | 0.022 0.014 DB14682 0.02 0.016 DBMET00225 0.025 0.012 DBMET01318 | DBMET01318 | |
| 0.158 | 0.16 | 0.194 | DNA damaging | 0.163 0.154 DB14682 0.167 0.149 DBMET00225 0.184 0.13 DBMET00595 0.172 0.143 DBMET01318 0.194 0.12 DBMET01319 | DBMET01319 | |
| 0.096 | 0.1 | 0.122 | Microtubule formation inhibitor | 0.122 0.058 DBMET00595 0.119 0.062 DBMET01319 | DBMET00595 | |
| 0.086 | 0.091 | 0.145 | Estrogen receptor beta antagonist | 0.145 0.017 DB14682 0.141 0.018 DBMET01318 | DB14682 | |
| 0.046 | 0.051 | 0.314 | NMDA 2B receptor antagonist | 0.099 0.016 DB14682 0.314 0.004 DBMET01317 0.056 0.035 DBMET01318 0.269 0.005 DBMET01320 | DBMET01317 | |
| 0.13 | 0.135 | 0.379 | Hepatoprotectant | 0.157 0.103 DB14682 0.379 0.015 DBMET00595 0.179 0.081 DBMET01317 0.357 0.018 DBMET01319 0.147 0.113 DBMET01320 | DBMET00595 | |
| 0.091 | 0.1 | 0.223 | Alkylator | 0.112 0.076 DB14682 0.223 0.021 DBMET00595 0.18 0.033 DBMET01319 | DBMET00595 | |
| 0.023 | 0.035 | 0.03 | Complement C5a chemotactic receptor antagonist | 0.03 0.02 DBMET00225 | DBMET00225 | |
| 0.031 | 0.05 | 0.076 | Neurokinin 1 antagonist | 0.076 0.011 DBMET00225 0.062 0.014 DBMET01318 | DBMET00225 | |
| 0.137 | 0.158 | 0.22 | Neurotrophic factor enhancer | 0.214 0.064 DB14682 0.22 0.059 DBMET00595 0.205 0.071 DBMET01318 0.211 0.066 DBMET01319 | DBMET00595 | |
| 0.118 | 0.139 | 0.305 | Interferon gamma antagonist | 0.142 0.09 DB14682 0.136 0.099 DBMET00225 0.261 0.026 DBMET00595 0.162 0.064 DBMET01318 0.305 0.019 DBMET01319 | DBMET01319 | |
| 0.024 | 0.046 | 0.035 | 5-Alpha-reductase inhibitor | 0.035 0.028 DB14682 | DB14682 | |
| 0.031 | 0.055 | 0.192 | Estrogen agonist | 0.106 0.016 DB14682 0.062 0.029 DBMET00595 0.192 0.008 DBMET01317 0.101 0.017 DBMET01318 0.058 0.031 DBMET01319 0.187 0.009 DBMET01320 | DBMET01317 | |
| 0.021 | 0.045 | 0.03 | Progesterone antagonist | 0.03 0.029 DBMET01318 | DBMET01318 | |
| 0.052 | 0.076 | 0.062 | Heme oxygenase stimulant | 0.062 0.042 DB14682 0.061 0.044 DBMET01318 | DB14682 | |
| 0.03 | 0.057 | 0.039 | Guanylate cyclase inhibitor | 0.039 0.034 DBMET00595 | DBMET00595 | |
| 0.125 | 0.152 | 0.14 | Ca2+-transporting ATPase inhibitor | 0.14 0.074 DB14682 0.135 0.093 DBMET00595 0.132 0.106 DBMET01318 | DB14682 | |
| 0.027 | 0.055 | 0.075 | Substance P antagonist | 0.075 0.008 DBMET00225 0.058 0.013 DBMET01318 | DBMET00225 | |
| 0.073 | 0.108 | 0.249 | Expectorant | 0.249 0.013 DBMET00595 0.22 0.017 DBMET01319 | DBMET00595 | |
| 0.048 | 0.083 | 0.067 | Lipocortins synthesis agonist | 0.067 0.025 DBMET00595 0.067 0.024 DBMET01319 | DBMET01319 | |
| 0.062 | 0.097 | 0.096 | Estrogen receptor alpha antagonist | 0.096 0.03 DB14682 0.091 0.034 DBMET01318 | DB14682 | |
| 0.025 | 0.064 | 0.249 | Dopamine D5 agonist | 0.074 0.007 DB14682 0.094 0.005 DBMET00225 0.249 0.002 DBMET01318 0.057 0.013 DBMET01320 | DBMET01318 | |
| 0.04 | 0.08 | 0.091 | Androgen agonist | 0.073 0.028 DB14682 0.055 0.049 DBMET01317 0.091 0.018 DBMET01318 0.069 0.032 DBMET01320 | DBMET01318 | |
| 0.071 | 0.111 | 0.099 | CC chemokine 5 receptor agonist | 0.098 0.023 DB14682 0.086 0.045 DBMET01317 0.099 0.023 DBMET01318 0.087 0.043 DBMET01320 | DBMET01318 | |
| 0.073 | 0.115 | 0.126 | Anabolic | 0.114 0.046 DB14682 0.123 0.037 DBMET01317 0.117 0.043 DBMET01318 0.126 0.034 DBMET01320 | DBMET01320 | |
| 0.031 | 0.079 | 0.072 | Neurokinin antagonist | 0.072 0.019 DBMET00225 0.061 0.024 DBMET01318 | DBMET00225 | |
| 0.055 | 0.104 | 0.12 | Androgen antagonist | 0.101 0.046 DB14682 0.12 0.033 DBMET01318 | DBMET01318 | |
| 0.145 | 0.195 | 0.31 | Superoxide dismutase inhibitor | 0.24 0.081 DBMET00225 0.19 0.129 DBMET01317 0.265 0.066 DBMET01318 0.31 0.047 DBMET01320 | DBMET01320 | |
| 0.008 | 0.062 | 0.097 | Estrogen receptor beta agonist | 0.087 0.013 DB14682 0.096 0.012 DBMET01317 0.088 0.013 DBMET01318 0.097 0.012 DBMET01320 | DBMET01320 | |
| 0.007 | 0.063 | 0.061 | Estrogen receptor alpha agonist | 0.061 0.015 DB14682 0.059 0.015 DBMET01318 | DB14682 | |
| 0.027 | 0.085 | 0.058 | Aromatase inhibitor | 0.058 0.043 DBMET01318 | DBMET01318 | |
| 0.038 | 0.098 | 0.053 | Factor III inhibitor | 0.051 0.033 DBMET00595 0.053 0.027 DBMET01319 | DBMET01319 | |
| 0.096 | 0.166 | 0.144 | Arachidonic acid antagonist | 0.132 0.11 DB14682 0.144 0.096 DBMET01318 | DBMET01318 | |
| 0.011 | 0.081 | 0.035 | Dipeptidyl peptidase I inhibitor | 0.035 0.016 DBMET00225 0.032 0.019 DBMET01318 | DBMET00225 | |
| 0.017 | 0.088 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | 0.038 0.033 DB14682 | DB14682 | |
| 0.051 | 0.126 | 0.128 | Glycine receptor antagonist | 0.072 0.07 DB14682 0.121 0.017 DBMET00595 0.121 0.018 DBMET01317 0.078 0.059 DBMET01318 0.128 0.014 DBMET01319 0.128 0.014 DBMET01320 | DBMET01320 | |
| 0.018 | 0.098 | 0.029 | Toll-Like receptor 4 agonist | 0.029 0.013 DBMET00595 0.029 0.013 DBMET01317 0.028 0.014 DBMET01319 0.028 0.014 DBMET01320 | DBMET01317 | |
| 0.006 | 0.086 | 0.135 | Estrone sulfatase inhibitor | 0.127 0.004 DBMET01317 0.135 0.004 DBMET01320 | DBMET01320 | |
| 0.055 | 0.138 | 0.081 | HIV-1 integrase (Overall Integration) inhibitor | 0.081 0.077 DB14682 | DB14682 | |
| 0.048 | 0.134 | 0.08 | Histamine N-methyltransferase inhibitor | 0.08 0.067 DB14682 | DB14682 | |
| 0.024 | 0.11 | 0.039 | GHS receptor agonist | 0.039 0.036 DBMET00225 | DBMET00225 | |
| 0.073 | 0.163 | 0.259 | Cyclooxygenase 3 inhibitor | 0.216 0.014 DBMET00595 0.259 0.008 DBMET01319 | DBMET01319 | |
| 0.019 | 0.111 | 0.034 | Estrogen-related receptor beta antagonist | 0.034 0.018 DB14682 0.032 0.024 DBMET01318 | DB14682 | |
| 0.039 | 0.134 | 0.102 | Phosphodiesterase IV inhibitor | 0.102 0.044 DBMET00225 | DBMET00225 | |
| 0.059 | 0.155 | 0.101 | Cystathionine beta-synthase inhibitor | 0.101 0.075 DB14682 | DB14682 | |
| 0.096 | 0.2 | 0.206 | Melanin inhibitor | 0.166 0.063 DBMET00595 0.141 0.095 DBMET01318 0.206 0.038 DBMET01319 | DBMET01319 | |
| 0.16 | 0.265 | 0.394 | Histamine release inhibitor | 0.228 0.173 DB14682 0.394 0.079 DBMET00595 0.269 0.142 DBMET01319 | DBMET00595 | |
| 0.022 | 0.128 | 0.047 | Phenylethanolamine N methyltransferase inhibitor | 0.041 0.027 DBMET00225 0.047 0.018 DBMET01318 | DBMET01318 | |
| 0.03 | 0.137 | 0.069 | Glucose-6-phosphate translocase inhibitor | 0.069 0.017 DBMET00595 0.065 0.019 DBMET01319 | DBMET00595 | |
| 0.031 | 0.155 | 0.109 | Na+ K+ transporting ATPase inhibitor | 0.095 0.037 DBMET00595 0.078 0.052 DBMET01318 0.109 0.023 DBMET01319 0.083 0.048 DBMET01320 | DBMET01319 | |
| 0.098 | 0.223 | 0.477 | Immunostimulant | 0.184 0.13 DB14682 0.477 0.032 DBMET00595 0.24 0.1 DBMET01317 0.165 0.143 DBMET01318 0.463 0.034 DBMET01319 0.22 0.109 DBMET01320 | DBMET00595 | |
| 0.039 | 0.167 | 0.087 | Somatostatin 1 agonist | 0.072 0.062 DB14682 0.087 0.044 DBMET01318 | DBMET01318 | |
| 0.088 | 0.223 | 0.171 | Adenylate cyclase stimulant | 0.131 0.1 DB14682 0.131 0.099 DBMET00225 0.171 0.035 DBMET01318 0.149 0.064 DBMET01320 | DBMET01318 | |
| 0.104 | 0.244 | 0.509 | Antioxidant | 0.185 0.127 DB14682 0.478 0.023 DBMET00595 0.229 0.096 DBMET01317 0.226 0.098 DBMET01318 0.509 0.019 DBMET01319 0.263 0.077 DBMET01320 | DBMET01319 | |
| 0.126 | 0.267 | 0.377 | Cholesterol antagonist | 0.377 0.055 DBMET00595 0.228 0.142 DBMET01317 0.345 0.066 DBMET01319 0.199 0.165 DBMET01320 | DBMET00595 | |
| 0.132 | 0.273 | 0.284 | Vasodilator, coronary | 0.284 0.102 DBMET00595 0.278 0.107 DBMET01319 | DBMET00595 | |
| 0.053 | 0.201 | 0.082 | Interleukin 5 antagonist | 0.082 0.068 DBMET01319 | DBMET01319 | |
| 0.021 | 0.17 | 0.142 | Antineoplastic antibiotic | 0.141 0.033 DBMET00595 0.142 0.033 DBMET01319 | DBMET01319 | |
| 0.056 | 0.207 | 0.252 | Lipid peroxidase inhibitor | 0.116 0.098 DB14682 0.226 0.032 DBMET00595 0.148 0.07 DBMET01318 0.252 0.026 DBMET01319 | DBMET01319 | |
| 0.083 | 0.236 | 0.396 | Hemostatic | 0.377 0.009 DBMET00595 0.357 0.011 DBMET01317 0.396 0.008 DBMET01319 0.376 0.009 DBMET01320 | DBMET01319 | |
| 0.06 | 0.213 | 0.101 | Phosphodiesterase 6D inhibitor | 0.101 0.051 DBMET00595 0.092 0.07 DBMET01319 | DBMET00595 | |
| 0.044 | 0.213 | 0.111 | Cholesterol synthesis inhibitor | 0.096 0.093 DBMET01318 0.111 0.074 DBMET01320 | DBMET01320 | |
| 0.051 | 0.222 | 0.2 | Multidrug resistance-associated protein 1 inhibitor | 0.2 0.01 DBMET01317 0.179 0.015 DBMET01320 | DBMET01317 | |
| 0.004 | 0.175 | 0.085 | Arginase inhibitor | 0.045 0.018 DBMET00595 0.049 0.016 DBMET01318 0.085 0.005 DBMET01319 | DBMET01319 | |
| 0.021 | 0.199 | 0.051 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.051 0.041 DBMET01318 | DBMET01318 | |
| 0.027 | 0.207 | 0.072 | Phospholipase D inhibitor | 0.072 0.05 DBMET01320 | DBMET01320 | |
| 0.004 | 0.189 | 0.277 | Cholecystokinin B antagonist | 0.276 0.004 DBMET01317 0.277 0.004 DBMET01320 | DBMET01320 | |
| 0.018 | 0.213 | 0.092 | Alpha-mannosidase inhibitor | 0.066 0.02 DBMET00595 0.092 0.008 DBMET01319 0.054 0.036 DBMET01320 | DBMET01319 | |
| 0.08 | 0.275 | 0.198 | Non-steroidal antiinflammatory agent | 0.198 0.073 DBMET00595 0.164 0.1 DBMET01319 | DBMET00595 | |
| 0.074 | 0.27 | 0.151 | DNA methylase inhibitor | 0.151 0.116 DBMET00595 | DBMET00595 | |
| 0.03 | 0.239 | 0.093 | Adrenaline agonist | 0.093 0.042 DBMET01318 | DBMET01318 | |
| 0.035 | 0.254 | 0.126 | Creatine kinase inhibitor | 0.126 0.037 DB14682 0.117 0.043 DBMET01318 | DB14682 | |
| 0.071 | 0.292 | 0.285 | Insulin secretagoues | 0.137 0.088 DBMET00225 0.206 0.033 DBMET00595 0.154 0.07 DBMET01318 0.285 0.014 DBMET01319 | DBMET01319 | |
| 0.016 | 0.241 | 0.083 | Protein 50S ribosomal subunit inhibitor | 0.082 0.019 DBMET00595 0.083 0.018 DBMET01319 | DBMET01319 | |
| 0.1 | 0.327 | 0.401 | DNA synthesis inhibitor | 0.187 0.143 DBMET00225 0.299 0.044 DBMET00595 0.244 0.07 DBMET01318 0.401 0.021 DBMET01319 | DBMET01319 | |
| 0.005 | 0.24 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.029 0.014 DBMET00595 0.035 0.01 DBMET01319 | DBMET01319 | |
| 0.049 | 0.289 | 0.11 | DOPA decarboxylase inhibitor | 0.11 0.059 DBMET01318 | DBMET01318 | |
| 0.005 | 0.245 | 0.283 | Cholecystokinin antagonist | 0.279 0.004 DBMET01317 0.283 0.004 DBMET01320 | DBMET01320 | |
| 0.04 | 0.295 | 0.085 | MAP kinase kinase 7 inhibitor | 0.085 0.033 DBMET01318 | DBMET01318 | |
| 0.06 | 0.316 | 0.282 | Interleukin agonist | 0.245 0.082 DBMET00595 0.282 0.058 DBMET01319 | DBMET01319 | |
| 0.011 | 0.267 | 0.083 | Mannosidase inhibitor | 0.052 0.024 DBMET00595 0.083 0.008 DBMET01319 | DBMET01319 | |
| 0.035 | 0.294 | 0.176 | AMP-activated protein kinase stimulant | 0.176 0.016 DBMET00595 0.167 0.019 DBMET01319 | DBMET00595 | |
| 0.007 | 0.271 | 0.041 | Sodium/glucose cotransporter inhibitor | 0.028 0.013 DBMET00595 0.041 0.007 DBMET01319 | DBMET01319 | |
| 0.121 | 0.39 | 0.393 | Interleukin 2 agonist | 0.217 0.161 DB14682 0.387 0.031 DBMET00595 0.225 0.149 DBMET01318 0.393 0.029 DBMET01319 | DBMET01319 | |
| 0.125 | 0.414 | 0.688 | Cyclophilin D inhibitor | 0.682 0.016 DBMET00595 0.25 0.213 DBMET01317 0.688 0.015 DBMET01319 0.252 0.211 DBMET01320 | DBMET01319 | |
| 0.073 | 0.362 | 0.179 | ATPase inhibitor | 0.179 0.059 DBMET00595 0.142 0.116 DBMET01319 | DBMET00595 | |
| 0.106 | 0.399 | 0.206 | GABA C receptor rho-3 antagonist | 0.206 0.2 DB14682 | DB14682 | |
| 0.037 | 0.331 | 0.103 | DNA polymerase I inhibitor | 0.102 0.084 DBMET00595 0.103 0.083 DBMET01319 | DBMET01319 | |
| 0.004 | 0.302 | 0.314 | Cholecystokinin A antagonist | 0.297 0.004 DBMET01317 0.314 0.004 DBMET01320 | DBMET01320 | |
| 0.041 | 0.346 | 0.114 | Transcription factor NF kappa B stimulant | 0.107 0.033 DBMET00595 0.114 0.028 DBMET01319 | DBMET01319 | |
| 0.083 | 0.391 | 0.534 | Antithrombotic | 0.524 0.026 DBMET00595 0.267 0.113 DBMET01317 0.534 0.025 DBMET01319 0.275 0.107 DBMET01320 | DBMET01319 | |
| 0.09 | 0.407 | 0.137 | CC chemokine 6 receptor antagonist | 0.137 0.049 DBMET00595 0.135 0.052 DBMET01319 | DBMET00595 | |
| 0.026 | 0.343 | 0.099 | ATPase (Vacuolar H+) inhibitor | 0.096 0.046 DBMET00595 0.099 0.041 DBMET01319 | DBMET01319 | |
| 0.131 | 0.45 | 0.306 | 5 Hydroxytryptamine release inhibitor | 0.242 0.239 DBMET01318 0.306 0.158 DBMET01319 | DBMET01319 | |
| 0.017 | 0.345 | 0.085 | Inducible nitric-oxide synthase inhibitor | 0.075 0.072 DBMET00225 0.085 0.054 DBMET01320 | DBMET01320 | |
| 0.005 | 0.334 | 0.035 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 DBMET01317 0.035 0.007 DBMET01320 | DBMET01320 | |
| 0.02 | 0.362 | 0.132 | Topoisomerase I inhibitor | 0.129 0.05 DBMET00595 0.132 0.049 DBMET01319 | DBMET01319 | |
| 0.037 | 0.383 | 0.539 | Angiogenesis stimulant | 0.514 0.011 DBMET00595 0.322 0.041 DBMET01317 0.539 0.01 DBMET01319 0.338 0.036 DBMET01320 | DBMET01319 | |
| 0.054 | 0.411 | 0.122 | DNA repair enzyme inhibitor | 0.122 0.068 DBMET00595 0.108 0.103 DBMET01319 | DBMET00595 | |
| 0.059 | 0.419 | 0.138 | Phospholipase C inhibitor | 0.138 0.134 DBMET01320 | DBMET01320 | |
| 0.03 | 0.391 | 0.155 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 DBMET00595 0.155 0.052 DBMET01319 | DBMET01319 | |
| 0.024 | 0.388 | 0.124 | GABA C receptor agonist | 0.124 0.047 DBMET01318 | DBMET01318 | |
| 0.023 | 0.391 | 0.107 | GABA C receptor antagonist | 0.107 0.068 DBMET01318 | DBMET01318 | |
| 0.09 | 0.461 | 0.347 | Apoptosis antagonist | 0.337 0.062 DBMET00595 0.347 0.057 DBMET01319 | DBMET01319 | |
| 0.042 | 0.414 | 0.388 | Free radical scavenger | 0.385 0.032 DBMET00595 0.388 0.031 DBMET01319 | DBMET01319 | |
| 0.029 | 0.406 | 0.083 | Thioredoxin inhibitor | 0.083 0.075 DBMET00595 0.082 0.078 DBMET01319 | DBMET00595 | |
| 0.012 | 0.392 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET01320 | DBMET01320 | |
| 0.029 | 0.432 | 0.245 | Amylase inhibitor | 0.129 0.076 DBMET00595 0.245 0.029 DBMET01319 | DBMET01319 | |
| 0.006 | 0.415 | 0.031 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DBMET00595 0.031 0.012 DBMET01319 | DBMET01319 | |
| 0.039 | 0.451 | 0.292 | Platelet adhesion inhibitor | 0.292 0.036 DBMET00595 0.201 0.071 DBMET01317 0.292 0.037 DBMET01319 0.198 0.072 DBMET01320 | DBMET01319 | |
| 0.115 | 0.535 | 0.342 | Calcium channel L-type activator | 0.342 0.123 DBMET01318 | DBMET01318 | |
| 0.023 | 0.467 | 0.058 | Adenine nucleotide translocase inhibitor | 0.052 0.049 DBMET00595 0.057 0.034 DBMET01317 0.053 0.047 DBMET01319 0.058 0.032 DBMET01320 | DBMET01320 | |
| 0.012 | 0.469 | 0.062 | Antibiotic Aminoglycoside-like | 0.06 0.009 DBMET00595 0.062 0.008 DBMET01319 | DBMET01319 | |
| 0.013 | 0.498 | 0.059 | Heparanase inhibitor | 0.052 0.041 DBMET00595 0.059 0.025 DBMET01319 | DBMET01319 | |
| 0.021 | 0.513 | 0.118 | Bone formation stimulant | 0.118 0.087 DBMET01318 0.106 0.099 DBMET01319 | DBMET01318 | |
| 0.003 | 0.502 | 0.548 | Cholecystokinin agonist | 0.509 0.002 DBMET01317 0.548 0.002 DBMET01320 | DBMET01320 | |
| 0.024 | 0.528 | 0.169 | Hypolipemic | 0.169 0.119 DBMET00595 0.149 0.137 DBMET01319 | DBMET00595 | |
| 0.053 | 0.563 | 0.335 | Immunomodulator | 0.335 0.065 DBMET00595 0.317 0.073 DBMET01319 | DBMET00595 | |
| 0.017 | 0.531 | 0.1 | UDP-glucose 4-epimerase inhibitor | 0.1 0.061 DBMET01319 | DBMET01319 | |
| 0.02 | 0.561 | 0.094 | Triose-phosphate isomerase inhibitor | 0.094 0.054 DBMET01320 | DBMET01320 | |
| 0.011 | 0.553 | 0.137 | Topoisomerase II inhibitor | 0.114 0.073 DBMET00595 0.137 0.056 DBMET01319 | DBMET01319 | |
| 0.01 | 0.553 | 0.61 | Cholecystokinin B agonist | 0.596 0.002 DBMET01317 0.61 0.002 DBMET01320 | DBMET01320 | |
| 0.003 | 0.548 | 0.372 | Cholecystokinin A agonist | 0.336 0.002 DBMET01317 0.372 0.002 DBMET01320 | DBMET01320 | |
| 0.007 | 0.56 | 0.052 | Elastase inhibitor | 0.052 0.038 DBMET01317 | DBMET01317 | |
| 0.005 | 0.559 | 0.106 | HIV-1 integrase (3'-Processing) inhibitor | 0.087 0.031 DBMET01317 0.106 0.024 DBMET01320 | DBMET01320 | |
| 0.04 | 0.598 | 0.603 | Antibacterial | 0.54 0.031 DBMET00595 0.603 0.019 DBMET01319 0.321 0.12 DBMET01320 | DBMET01319 | |
| 0.005 | 0.574 | 0.045 | NMDA 2D receptor antagonist | 0.036 0.012 DBMET01317 0.045 0.008 DBMET01320 | DBMET01320 | |
| 0.015 | 0.585 | 0.1 | Beta glucuronidase inhibitor | 0.1 0.069 DBMET01319 | DBMET01319 | |
| 0.011 | 0.585 | 0.189 | Protein-tyrosine phosphatase inhibitor | 0.171 0.061 DBMET01317 0.189 0.051 DBMET01320 | DBMET01320 | |
| 0.02 | 0.605 | 0.134 | Cell adhesion inhibitor | 0.134 0.056 DBMET00595 0.129 0.059 DBMET01319 | DBMET00595 | |
| 0.018 | 0.606 | 0.196 | Platelet antagonist | 0.18 0.117 DBMET00595 0.196 0.103 DBMET01319 | DBMET01319 | |
| 0.014 | 0.647 | 0.241 | Thrombolytic | 0.207 0.049 DBMET00595 0.241 0.036 DBMET01319 0.137 0.093 DBMET01320 | DBMET01319 | |
| 0.005 | 0.652 | 0.289 | Selectin antagonist | 0.281 0.006 DBMET00595 0.081 0.036 DBMET01317 0.289 0.006 DBMET01319 0.09 0.032 DBMET01320 | DBMET01319 | |
| 0.008 | 0.661 | 0.068 | Thrombin inhibitor | 0.068 0.058 DBMET01317 | DBMET01317 | |
| 0.017 | 0.677 | 0.207 | Cell wall synthesis inhibitor | 0.135 0.081 DBMET00595 0.207 0.027 DBMET01319 0.173 0.045 DBMET01320 | DBMET01319 | |
| 0.004 | 0.697 | 0.074 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 DBMET01317 0.074 0.034 DBMET01320 | DBMET01320 | |
| 0.009 | 0.712 | 0.347 | Anticoagulant | 0.134 0.095 DBMET00595 0.32 0.025 DBMET01317 0.148 0.082 DBMET01319 0.347 0.022 DBMET01320 | DBMET01320 | |
| 0.064 | 0.773 | 0.332 | Peptidyltransferase inhibitor | 0.33 0.016 DBMET00595 0.332 0.015 DBMET01319 | DBMET01319 | |
| 0.006 | 0.735 | 0.082 | CDC25A inhibitor | 0.068 0.061 DBMET01317 0.082 0.041 DBMET01320 | DBMET01320 | |
| 0.012 | 0.769 | 0.048 | Factor IXa inhibitor | 0.047 0.042 DBMET01319 0.048 0.041 DBMET01320 | DBMET01320 | |
| 0.007 | 0.77 | 0.036 | Purinergic P2Y2 antagonist | 0.032 0.025 DBMET01317 0.036 0.02 DBMET01320 | DBMET01320 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |